Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So it appears that it will be approved 30 days from today (9/15/2019) seems like that matches up with Medtronic's Sept 24 date!!!!!
Here is the take:
No way Medtronic schedules an analyst call for Sept 24 and highlights a major announcment on SP robotic surgery to rival ISRG if they don't have something already in place..
If they announce a SP system, it can only be Titan or Virtual Incision (and
any others I might be forgetting). They could also announce a Multi-port (i.e. CMR). Let's face it, they have to get going as well on robotic surgery.
So let's say Medtronic says either
a. We've developed our own SP
b. We've acquired a SP platfrom (Titan Medical, Virtual Incision)
c. We've developed our own Multi Port platform (even though PR mentions SP)
All of that is excellent news for Titan as the DOMINOES HAVE BEGUN TO FALL. It will be of the UTMOST IMPORTANCE that JNJ comes out with their rebranding of the Ethicon Digital Surgery Division (ENOS) sometime after Sept. 24. Maybe mid OCt? At that point JNJ will announce their Digital surgery platform. They already have endoluminal to compete with ISRG (Auris is much better platfrom), they will need a Multi-port (verb) and a single port (titan) to compete. Let the bidding begin.
FYI, I can't believe that ISRG will let these guys just steal the keys to locking up SP robotic surgery for the next ten/twenty years, esp with the patents Titan holds. If they don't come in with a $15B offer, they would be foolish. After all, most of their future success will come from converting Multi-port procedures to Single port to help expand the "Moat"
And the pps when the buyout is north of $8B..... at that price it’s all good.
It’s very possible Medtronic came in w a monster offer and stole this from JNJ!
Do some digging yourself. Confirmed that Microline is not making end effectors. Thanks for coming surgitek, ur time is coming to an end
He’s also working 2 jobs and hasn’t updated his LinkedIn page since 2017, AND he is the only guy that has worked on the end effectors in 2013-2014.
He was too lazy so he copied and pasted the same photo that is on Titan’s website.
Someone even posted on this forum that they spoke w him and he said that microline wasn’t working on end effectors any time after 2014. That post might have been deleted but u can check that.
So by rushing submission u mean ignoring everything they have been discussing with the fda for the last 10 months. By rushing submission, do you mean going thru the IDE approval process and getting fda approval for clinical trials. Which if any dd is done would realize the if fda grants fda approval then they have reviewed the data to date that would normally be reserved for fda approval and signed off on it.
Regulatory approval oversees by Jan 2020.
Confirmed, Microline IS NOT making titans end effectors.
Big picture - JNJ/Titan/Verb/Auris
Sport19 says that fda submission is in Q4
That’s right it was April 2015 and we know for fact that microline stopped working on end effectors in 2014. Hence Titan signing an agreement w a new WW Global supplier of end effectors in April 2015.
JnJ/Titan/Verb/Auris
Don't disagree, I am expecting an announcement of a raise any day now b/t $25-$40M.....but is hasn't come yet. We shall see, its possible another company has decided that its worth the risk to make a massive offer for Titan pre regulatory approval that would be to good to pass up.
After all, ISRG is betting their future on SINGLE PORT TECHNOLOGY and Titan is the only other game in town right now. And according to SPORT19, they will be submitting to FDA in Q4 2019
The guy was working on basic end effectors for titan when he started in 2013 and stopped working on them in 2014 - this was confirmed.
Of course we all know that in APRIL 2016, titan signs a new agreement with a new partner for end effectors
https://titanmedicalinc.com/titan-medical-inc-signs-agreement-with-worldwide-supplier-of-single-patient-use-robotic-tools/
what about your theory that they can only take 20% of MC based on the $125 Shelf offering - THAT IS ONLY $25M - so they are still way short of the $40M you say they need. So the question is....
HOW DO THEY MAKE UP THE DIFFERENCE B/T THE $40m YOU SAY THE NEED AND THE MAX RAISE OF $25m (based on 20% maximum you and your boy snapper agreed upon0?
Then why no announcement of raise? You said last friday.....
I'm sorry, 14 minutes AND 20 seconds
so it took you 14 minutes to read up on ALL Titan Patents and craft a reply that makes no sense. Really showing some due diligence.....
Follow the patents. some new updates and indications - very, very interesting stuff
https://patents.justia.com/assignee/titan-medical-inc
way to rally your boys to get this done (sigh)
Very stark difference b/t TRXC and TMDI
https://www.medtechdive.com/news/transenterix-admits-its-robotics-system-falls-short-for-docs-amid-sales-slu/560484/
Ok, so based on what you say, clinical trials 60 days and FDA submission in 120 days (4 months) - SPORT19 is saying that we can expect FDA Submission around 12/12/19. Mark it.
I thought making an a$$ of oneself is what this board is about
With each passing day that goes without an offering being announced, leads me to believe that significant negotiations are going on right now behind the scenes. Its worth the risk for a company like Stryker to come in now and make a bid for a pre-FDA approved SINGLE PORT surgical robotic platform that has had the clinical success to date of Titan. Too much risk for either JnJ, Medtronic, Stryker, Karl Storz to let the other one get the TITAN (TMDI) Single Port Platform.
Human Clinical trials are just over 30 days away.
Well for starters ISRG's $70 BILLION MARKET CAP is now UNPROTECTED when their patents expire. That is why ISRG was betting the FUTURE of a $70B Market Cap company on SINGLE PORT. They main goal is to convert a majority of these MULTI-PORT procedures to SINGLE PORT procedures SO anyone that wants to compete, the JNJ, MEDTRONIC, STRYKER, KARL STORZ, OLYMPUS, ETC will ABSOLUTELY NEED Single Port Platform.
Hmmmm, seems to me that their are more buyers then sellers of SINGLE PORT - let the bidding begin. Imagine if Stryker comes in and steals Single Port from either Medtronic or JNJ - the offer would have to be huge - north of $8 Billion.
Are you saying that Knobbe Martens is NOT PROSECUTING patents for Titan Medical?
OR
Are you saying that Knobbe Martens is NOT PROSECUTING patents for Auris?
Man, this looks like one of the top firms in the world,
"Knobbe Martens is one of America's largest Intellectual Property
and technology law firms — a team of smart, aggressive attorneys,
scientists and technical experts committed to promoting
and protecting innovation."
https://www.knobbe.com/
So interesting that they are executing patents for "competitors" in the surgical robotic space.
Ran across this Intellectual Patent firm called Knobbe Martens - who has represented both Auris and Titan on patents for robotic surgery.
JnJ/Titan/Verb/Auris
Have Patients
Sorry to call you out but SPORT19 said FDA Submission in 4 months so must be wrong or one of you is wrong.
Gotta love TRXC
https://seekingalpha.com/news/3490600-transenterix-4-percent-premarket-25m-stock-sales-deal
Compare Titan and TRXC and it will really highlight the difference b/t a company with no future (TRXC) and a company with a bright future (Titan)
Please tag this post, SPORT19 is now saying that FDA submittal is 4 months away. Again though, if you are thinking they are going it alone - no need to touch this for awhile - but that means you believe those that are saying Titan is going alone
Pssst....they are wrong
Someone please tag SPORT19 post about Titan gaining FDA SUBMITTAL in Q4 2019
Oh, so fda is potentially 3 months away- thanks for clarifying surgitek - fda submittal In Q4 2019!
And some say don’t invest it’s going down and they are going it alone. Jnj/Titan/Verb/Auris. Have to agree
Hey HC777, ISRG is trying to get more indications for its own Single Port platform. So r u saying pay off for more indications and to hold back Titan?
What is this looney land?
So once they submit for FDA approval (slated for Q1 next 2020 - 4 months away), we can expect approval 4-7 months later.
Your the numbers guys, they burn thru the $125M when FDA says your approved in August 2020, how much will they need to get thru August 2021 - based off TRXC which needed $350M since FDA approval and that was a copmany that struggleds. Cost would be higher if demand is higher
HC777, question, once they submit for FDA, what timeframe do you expect from SUBMITTAL to FDA to APPROVAL by FDA? 3 months? 6 months? 9 months?
I'd ask SPORT19 but that guy knows squat about medical
you are actually right for once , that is one of the reasons they aren't investing - they will be well taken care of on the buyout. What do you want them to pull the Pope/Slattery buying and selling of shares/options - oh that is right, TRXC is toast.
JnJ/Titan/Verb/Auris
Note for all investors:
IF TITAN IS PLANNING ON GOING IT ALONE THEY WILL NEED ALMOST $250-350 MILLION on top of the $125 shelf!!!
IF you think they are going it alone, then do not invest b/c it will be diluted to oblivion and wait to buy until late 2021 or early 2022 to invest.
If you are invested already and think they are going it alone you are better off selling now b/c at $2.50 it will hover at this for another 2 to 2 1/2 years so you can always buy on the offerings b/c they will end up having to do 10-12 offerings over that time.
If you think they are going it alone - don't touch it.
By loosing money, do you mean jingling it in your pocket b/c it is stuck to some day old gum. Or do you mean LOSING money?